Torthaí cuardaigh - Wang-Gillam, Andrea
- 1 - 20 toradh as 65 á dtaispeáint
- Téigh chuig an gcéad leathanach eile
-
1
Entering the molecular era of gastrointestinal oncology: current updates and challenges de réir Wang-Gillam, Andrea, Lim, Kian-Huat
Foilsithe / Cruthaithe 2017Téacs -
2
Promising therapeutics of gastrointestinal cancers in clinical trials de réir Du, Lingling, Che, Zheng, Wang-Gillam, Andrea
Foilsithe / Cruthaithe 2017Téacs -
3
-
4
-
5
Nab-paclitaxel monotherapy in refractory pancreatic adenocarcinoma de réir Peddi, Parvin F., Cho, May, Wang, Jian, Gao, Feng, Wang-Gillam, Andrea
Foilsithe / Cruthaithe 2013Téacs -
6
Racial Disparities in the Outcomes of Patients With Stage IV Pancreatic Adenocarcinoma are Mediated by Chemotherapy Utilization de réir Atkins, Jordan J., Fiala, Mark A., Wang-Gillam, Andrea, Wildes, Tanya M.
Foilsithe / Cruthaithe 2016Téacs -
7
Chemotherapy-associated Posterior Reversible Encephalopathy Syndrome: A Case Report and Review of the Literature de réir How, Joan, Blattner, Margaret, Fowler, Susan, Wang-Gillam, Andrea, Schindler, Suzanne E
Foilsithe / Cruthaithe 2016Téacs -
8
Neoadjuvant Therapy of Pancreatic Cancer: The Emerging Paradigm? de réir Lim, Kian-Huat, Chung, Eugene, Khan, Adeel, Cao, Dengfeng, Linehan, David, Ben-Josef, Edgar, Wang-Gillam, Andrea
Foilsithe / Cruthaithe 2012Téacs -
9
Phase II Trial of Gemcitabine and Tanespimycin (17AAG) in Metastatic Pancreatic Cancer: A Mayo Clinic Phase II Consortium Study de réir Pedersen, Katrina S., Kim, George P., Foster, Nathan R., Wang-Gillam, Andrea, Erlichman, Charles, McWilliams, Robert R.
Foilsithe / Cruthaithe 2015Téacs -
10
Vitamin D deficiency and prognostics among patients with pancreatic adenocarcinoma de réir Cho, May, Peddi, Parvin F, Ding, Kevin, Chen, Ling, Thomas, Denise, Wang, Jian, Lockhart, Albert C, Tan, Benjamin, Wang-Gillam, Andrea
Foilsithe / Cruthaithe 2013Téacs -
11
Immunogenicity of influenza vaccination in patients with cancer de réir Waqar, Saiama N., Boehmer, Leigh, Morgensztern, Daniel, Wang-Gillam, Andrea, Sorscher, Steven, Lawrence, Steven, Gao, Feng, Guebert, Kalin, Williams, Kristina, Govindan, Ramaswamy
Foilsithe / Cruthaithe 2018Téacs -
12
Concurrent HER or PI3K Inhibition Potentiates the Anti-tumor Effect of ERK Inhibitor Ulixertinib in Preclinical Pancreatic Cancer Models de réir Jiang, Hongmei, Xu, Mai, Li, Lin, Grierson, Patrick, Dodhiawala, Paarth, Highkin, Maureen, Zhang, Daoxiang, Li, Qiong, Wang-Gillam, Andrea, Lim, Kian-Huat
Foilsithe / Cruthaithe 2018Téacs -
13
Tumor-Stroma IL-1β-IRAK4 Feedforward Circuitry Drives Tumor Fibrosis, Chemoresistance, And Poor Prognosis In Pancreatic Cancer de réir Zhang, Daoxiang, Li, Lin, Jiang, Hongmei, Li, Qiong, Wang-Gillam, Andrea, Yu, Jinsheng, Head, Richard, Liu, Jingxia, Ruzinova, Marianna B., Lim, Kian-Huat
Foilsithe / Cruthaithe 2018Téacs -
14
Metformin Downregulates PD-L1 Expression in Esophageal Squamous Cell Carcinoma by Inhibiting IL-6 Signaling Pathway de réir Lu, Yao, Xin, Dao, Guan, Lulu, Xu, Mengli, Yang, Yalan, Chen, Yu, Yang, Yuanyuan, Wang-Gillam, Andrea, Wang, Li, Zong, Shanggang, Wang, Feng
Foilsithe / Cruthaithe 2021Téacs -
15
Constitutive IRAK4 Activation Underlies Poor Prognosis and Chemoresistance In Pancreatic Ductal Adenocarcinoma de réir Zhang, Daoxiang, Li, Lin, Jiang, Hongmei, Knolhoff, Brett, Lockhart, Albert C., Wang-Gillam, Andrea, DeNardo, David G., Ruzinova, Marianna B., Lim, Kian-Huat
Foilsithe / Cruthaithe 2016Téacs -
16
Phase II trial of levocetirizine with capecitabine and bevacizumab to overcome the resistance of antiangiogenic therapies in refractory metastatic colorectal cancer de réir Amin, Manik, Desai, Monica, Trinkaus, Kathryn, Brown, Amberly, Wang-Gillam, Andrea, Tan, Benjamin, Picus, Joel, Sorscher, Steven, Highkin, Maureen, Lears, Kim, Lockhart, Albert C.
Foilsithe / Cruthaithe 2019Téacs -
17
A phase I study of subcutaneously administered aflibercept (VEGF trap) in a new formulation in patients with advanced solid tumors de réir Wang-Gillam, Andrea, Tew, William P., Rothenberg, Mace L., Dupont, Jakob, Cooper, Wendy, Sternas, Lars, Buzenet, Giliane, Sosman, Jeffrey A., Spriggs, David R., Lockhart, Albert Craig
Foilsithe / Cruthaithe 2011Téacs -
18
TPL2 enforces RAS-induced inflammatory signaling and is activated by point mutations de réir Dodhiawala, Paarth B., Khurana, Namrata, Zhang, Daoxiang, Cheng, Yi, Li, Lin, Wei, Qing, Seehra, Kuljeet, Jiang, Hongmei, Grierson, Patrick M., Wang-Gillam, Andrea, Lim, Kian-Huat
Foilsithe / Cruthaithe 2020Téacs -
19
Ablative Five-Fraction Stereotactic Body Radiation Therapy for Inoperable Pancreatic Cancer Using Online MR-Guided Adaptation de réir Hassanzadeh, Comron, Rudra, Soumon, Bommireddy, Ani, Hawkins, William G., Wang-Gillam, Andrea, Fields, Ryan C., Cai, Bin, Park, Justin, Green, Olga, Roach, Michael, Henke, Lauren, Kim, Hyun
Foilsithe / Cruthaithe 2020Téacs -
20
CSF1/CSF1R Blockade Reprograms Tumor-Infiltrating Macrophages and Improves Response to T Cell Checkpoint Immunotherapy in Pancreatic Cancer Models de réir Zhu, Yu, Knolhoff, Brett L., Meyer, Melissa A., Nywening, Timothy M., West, Brian L., Luo, Jingqin, Wang-Gillam, Andrea, Goedegebuure, S Peter, Linehan, David C., DeNardo, David G.
Foilsithe / Cruthaithe 2014Téacs